Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Anti-GTPase HRAS antibody [Y132]
See all GTPase HRAS products (5) ...
Rabbit monoclonal [Y132] to GTPase HRAS
Reactivity with other RAS members has not, to our knowledge, been tested.
WB, ICC/IF, IPmore details
Reacts with
Mouse, Rat, Human
Predicted to work with
Chicken
A synthetic peptide corresponding to residues in the C-terminus of human H-Ras.
MCF7 and PC12 cell lysates and MCF7 cells.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, 0.15M Sodium chloride, 50mM Tris glycine. pH 7.4
Concentration information loading...
Protein A purified
Monoclonal
Y132
IgG
Cancer >> Signal transduction >> G protein signaling >> Small G proteins >> Ras family
Epigenetics and Nuclear Signaling >> Transcription >> Cancer susceptibility >> Proto-oncogenes
Cell Biology >> Cell Cycle >> Cell differentiation
Signal Transduction >> Signaling Pathway >> G Protein Signaling >> Small G Proteins >> Ras Family
Signal Transduction >> Second Messenger >> Nucleotide Messenger >> GTP
Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Our Abpromise guarantee covers the use of ab32417 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/500Detects a band of approximately 21 kDa.
ICC/IF: 1/100 - 1/250.
IP: 1/50
Is unsuitable for ,Flow Cyt or IHC.
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
Defects in HRAS are the cause of Costello syndrome (COSTS) [MIM:218040]; also known as faciocutaneoskeletal syndrome. Costello syndrome is a rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.
Defects in HRAS are the cause of congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]. CMEMS is a variant of Costello syndrome.
Defects in HRAS may be a cause of susceptibility to Hurthle cell thyroid carcinoma (HCTC) [MIM:607464]. Hurthle cell thyroid carcinoma accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms.
Note=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors.
Defects in HRAS are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.
Note=Defects in HRAS are the cause of oral squamous cell carcinoma (OSCC).
Belongs to the small GTPase superfamily. Ras family.
Palmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
S-nitrosylated; critical for redox regulation. Important for stimulating guanine nucleotide exchange. No structural perturbation on nitrosylation.
Cell membrane. Golgi apparatus membrane. Shuttles between the plasma membrane and the Golgi apparatus.
Target information above from: UniProt accessionP01112
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - GTPase HRAS antibody [Y132] (ab32417)
![Western blot - GTPase HRAS antibody [Y132] (ab32417)](/ps/datasheet/Images/32/ab32417/ab32417wb.gif)
All lanes : Anti-GTPase HRAS antibody [Y132] (ab32417) at 1/500 dilution
Lane 1 : MCF7 cell lysate
Lane 2 : PC12 cell lysate
Observed band size : 21 kDa (why is the actual band size different from the predicted?)
Immunocytochemistry/ Immunofluorescence - GTPase HRAS antibody [Y132] (ab32417)
![Immunocytochemistry/ Immunofluorescence - GTPase HRAS antibody [Y132] (ab32417)](/ps/datasheet/Images/32/ab32417/ab32417if.jpg)
Immunohistochemical staining of MCF7 cells using ab32417 at 1/100 dilution.
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab32417? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Western blot - GTPase HRAS antibody [Y132] (ab32417)](/ps/datasheet/Images/32/ab32417/ab32417wb.gif)
All lanes : Anti-GTPase HRAS antibody [Y132] (ab32417) at 1/500 dilution
Lane 1 : MCF7 cell lysate
Lane 2 : PC12 cell lysate
Observed band size : 21 kDa (why is the actual band size different from the predicted?)
![Immunocytochemistry/ Immunofluorescence - GTPase HRAS antibody [Y132] (ab32417)](/ps/datasheet/Images/32/ab32417/ab32417if.jpg)
Immunohistochemical staining of MCF7 cells using ab32417 at 1/100 dilution.
1
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
